Cargando…

The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count

OBJECTIVE: This study aimed to assess the association of clinical factors with P2Y(12)-dependent platelet inhibition as monitored by the ratio of ADP- to TRAP-induced platelet aggregation and conventional ADP-induced aggregation, respectively. BACKGROUND: Controversial findings to identify and overc...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivier, Christoph B., Meyer, Melanie, Bauer, Hans, Schnabel, Katharina, Weik, Patrick, Zhou, Qian, Bode, Christoph, Moser, Martin, Diehl, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757031/
https://www.ncbi.nlm.nih.gov/pubmed/26885820
http://dx.doi.org/10.1371/journal.pone.0149053
_version_ 1782416442707148800
author Olivier, Christoph B.
Meyer, Melanie
Bauer, Hans
Schnabel, Katharina
Weik, Patrick
Zhou, Qian
Bode, Christoph
Moser, Martin
Diehl, Philipp
author_facet Olivier, Christoph B.
Meyer, Melanie
Bauer, Hans
Schnabel, Katharina
Weik, Patrick
Zhou, Qian
Bode, Christoph
Moser, Martin
Diehl, Philipp
author_sort Olivier, Christoph B.
collection PubMed
description OBJECTIVE: This study aimed to assess the association of clinical factors with P2Y(12)-dependent platelet inhibition as monitored by the ratio of ADP- to TRAP-induced platelet aggregation and conventional ADP-induced aggregation, respectively. BACKGROUND: Controversial findings to identify and overcome high platelet reactivity (HPR) after coronary stent-implantation and to improve clinical outcome by tailored anti-platelet therapy exist. Monitoring anti-platelet therapy ex vivo underlies several confounding parameters causing that ex vivo platelet aggregation might not reflect in vivo platelet inhibition. METHODS: In a single centre observational study, multiple electrode aggregometry was performed in whole blood of patients after recent coronary stent-implantation. Relative ADP-induced aggregation (r-ADP-agg) was defined as the ratio of ADP- to TRAP- induced aggregation reflecting the individual degree of P2Y(12)-mediated platelet reactivity. RESULTS: Platelet aggregation was assessed in 359 patients. Means (± SD) of TRAP-, ADP-induced aggregation and r-ADP-agg were 794 ± 239 AU*min, 297 ± 153 AU*min and 37 ± 14%, respectively. While ADP- and TRAP-induced platelet aggregation correlated significantly with platelet count (ADP: r = 0.302; p<0.001; TRAP: r = 0.509 p<0.001), r-ADP-agg values did not (r = -0.003; p = 0.960). These findings were unaltered in multivariate analyses adjusting for a range of factors potentially influencing platelet aggregation. The presence of an acute coronary syndrome and body weight were found to correlate with both ADP-induced platelet aggregation and r-ADP-agg. CONCLUSION: The ratio of ADP- to TRAP-induced platelet aggregation quantifies P2Y(12)-dependent platelet inhibition independently of the platelet count in contrast to conventional ADP-induced aggregation. Furthermore, r-ADP-agg was associated with the presence of an acute coronary syndrome and body weight as well as ADP-induced aggregation. Thus, the r-ADP-agg is a more valid reflecting platelet aggregation and potentially prognosis after coronary stent-implantation in P2Y(12)-mediated HPR than conventional ADP-induced platelet aggregation.
format Online
Article
Text
id pubmed-4757031
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47570312016-02-26 The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count Olivier, Christoph B. Meyer, Melanie Bauer, Hans Schnabel, Katharina Weik, Patrick Zhou, Qian Bode, Christoph Moser, Martin Diehl, Philipp PLoS One Research Article OBJECTIVE: This study aimed to assess the association of clinical factors with P2Y(12)-dependent platelet inhibition as monitored by the ratio of ADP- to TRAP-induced platelet aggregation and conventional ADP-induced aggregation, respectively. BACKGROUND: Controversial findings to identify and overcome high platelet reactivity (HPR) after coronary stent-implantation and to improve clinical outcome by tailored anti-platelet therapy exist. Monitoring anti-platelet therapy ex vivo underlies several confounding parameters causing that ex vivo platelet aggregation might not reflect in vivo platelet inhibition. METHODS: In a single centre observational study, multiple electrode aggregometry was performed in whole blood of patients after recent coronary stent-implantation. Relative ADP-induced aggregation (r-ADP-agg) was defined as the ratio of ADP- to TRAP- induced aggregation reflecting the individual degree of P2Y(12)-mediated platelet reactivity. RESULTS: Platelet aggregation was assessed in 359 patients. Means (± SD) of TRAP-, ADP-induced aggregation and r-ADP-agg were 794 ± 239 AU*min, 297 ± 153 AU*min and 37 ± 14%, respectively. While ADP- and TRAP-induced platelet aggregation correlated significantly with platelet count (ADP: r = 0.302; p<0.001; TRAP: r = 0.509 p<0.001), r-ADP-agg values did not (r = -0.003; p = 0.960). These findings were unaltered in multivariate analyses adjusting for a range of factors potentially influencing platelet aggregation. The presence of an acute coronary syndrome and body weight were found to correlate with both ADP-induced platelet aggregation and r-ADP-agg. CONCLUSION: The ratio of ADP- to TRAP-induced platelet aggregation quantifies P2Y(12)-dependent platelet inhibition independently of the platelet count in contrast to conventional ADP-induced aggregation. Furthermore, r-ADP-agg was associated with the presence of an acute coronary syndrome and body weight as well as ADP-induced aggregation. Thus, the r-ADP-agg is a more valid reflecting platelet aggregation and potentially prognosis after coronary stent-implantation in P2Y(12)-mediated HPR than conventional ADP-induced platelet aggregation. Public Library of Science 2016-02-17 /pmc/articles/PMC4757031/ /pubmed/26885820 http://dx.doi.org/10.1371/journal.pone.0149053 Text en © 2016 Olivier et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Olivier, Christoph B.
Meyer, Melanie
Bauer, Hans
Schnabel, Katharina
Weik, Patrick
Zhou, Qian
Bode, Christoph
Moser, Martin
Diehl, Philipp
The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
title The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
title_full The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
title_fullStr The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
title_full_unstemmed The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
title_short The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
title_sort ratio of adp- to trap-induced platelet aggregation quantifies p2y(12)-dependent platelet inhibition independently of the platelet count
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757031/
https://www.ncbi.nlm.nih.gov/pubmed/26885820
http://dx.doi.org/10.1371/journal.pone.0149053
work_keys_str_mv AT olivierchristophb theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT meyermelanie theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT bauerhans theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT schnabelkatharina theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT weikpatrick theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT zhouqian theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT bodechristoph theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT mosermartin theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT diehlphilipp theratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT olivierchristophb ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT meyermelanie ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT bauerhans ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT schnabelkatharina ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT weikpatrick ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT zhouqian ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT bodechristoph ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT mosermartin ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount
AT diehlphilipp ratioofadptotrapinducedplateletaggregationquantifiesp2y12dependentplateletinhibitionindependentlyoftheplateletcount